Develops biopharmaceutical products for the treatment of cardio metabolic and neurodegenerative diseases This is an ADR of a company whose stock trades outside of the U.S. as the symbol FP:GNFT.

$4.17  -0.03 (-0.71%)
As of 05/12/2021 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  France
Country of incorporation:  
IPO date:  01/27/2016
Outstanding shares:  45,775,250
Average volume:  20,526
Market cap:   $201,411,100
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    372279109
ISIN:        US3722791098
Valuation   (See tab for details)
PE ratio:   -1.93
PB ratio:   4.43
PS ratio:   21.76
Return on equity:   619.61%
Net income %:   -1,082.03%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy